The supplementation of vitamin B1, B6, and B12 for 90 days has shown to improve ankle, knee reflex, as well as motor strength in individuals suffering from peripheral neuropathy, a 90-day study from Procter and Gamble (P&G) Health has shown.
New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in-class cardiac myosin inhibitor, in adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently announced by Bristol Myers Squibb.
New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in-class cardiac myosin inhibitor, in adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently announced by Bristol Myers Squibb.
Results from VALOR-HCM LTE demonstrated that with longer follow-up, CAMZYOS continued to reduce eligibility for invasive SRT at 56 weeks
EXPLORER-LTE data showed sustained improvements in LVOT.